Back to search

Diffuse Aggressive Histologies of Non-Hodgkin Lymphoma: Treatment and Biology of Limited Disease

Data up to Jan 2025

Published2006
Citations13
References31

Total Citations Per Year

Abstract

References (31)

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

2000 • 9,712 citations

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

2002 • 5,269 citations

World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues

2002 • 4,781 citations

A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

1993 • 4,650 citations

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

2002 • 3,769 citations

WHO-EORTC classification for cutaneous lymphomas

2005 • 3,617 citations

A predictive model for aggressive non-Hodgkin's lymphoma

1993 • 3,483 citations

Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

2003 • 1,080 citations

Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma

1998 • 1,010 citations

Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

2005 • 958 citations

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma

2003 • 843 citations

Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group

2002 • 428 citations

Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484

2004 • 350 citations

ACVBP versus CHOP plus Radiotherapy for Localized Aggressive Lymphoma

2005 • 322 citations

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

2004 • 321 citations

Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling

2004 • 286 citations

Utility of Fine-Needle Aspiration As a Diagnostic Technique in Lymphoma

2004 • 275 citations

Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites

2000 • 197 citations

WHO Classification of Tumours: Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues

2003 • 154 citations

Brief Chemotherapy and Involved-Region Irradiation for Limited-Stage Diffuse Large-Cell Lymphoma: An 18-Year Experience From the British Columbia Cancer Agency

2002 • 111 citations

PET Scans in the Staging of Lymphoma: Current Status

2003 • 99 citations

CHEMOTHERAPY OF LOCALISED HISTIOCYTIC LYMPHOMA

1979 • 72 citations

Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.

2000 • 68 citations

Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B‐cell lymphomas of the testis and the central nervous system

2002 • 64 citations

Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.

1993 • 49 citations

T lymphocytes from invaded lymph nodes in patients with B-cell-derived non-Hodgkin's lymphoma: reactivity toward the malignant clone

1990 • 48 citations

Mutations in the HLA class�II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma

2003 • 38 citations

Effect of Adding Rituximab to Three Cycles of CHOP Plus Invoved-Field Radiotherapy for Limited-Stage Aggressive Diffuse B-Cell Lymphoma (SWOG-0014).

2004 • 37 citations

No Role for Chemoradiotherapy When Compared with Chemotherapy Alone in Elderly Patients with Localized Low Risk Aggressive Lymphoma: Final Results of the LNH93-4 GELA Study.

2005 • 25 citations

Histologic Subtypes Do Not Confer Unique Outcomes in Early-Stage Lymphoma: Long-Term Follow-Up of SWOG 8736.

2004 • 6 citations

A comparative study of cobalamin deficiency in African Americans with and without sickle cell disease

2003 • 3 citations

Cited By (0)

No citing papers found in database

Diffuse Aggressive Histologies of Non-Hodgkin Lymphoma: Treatment and Biology of Limited… (2006) – Seminars in Hematology | Metascience Observatory Explorer